By Acceleron | May 4, 2018

Acceleron Receives FDA Fast Track Designation for ACE-083 in Facioscapulohumeral Muscular Dystrophy (FSHD)

By Acceleron | September 26, 2017

Acceleron to Develop Sotatercept in PAH